2001
Quality of informed consent in cancer clinical trials: a cross-sectional survey
Joffe S, Cook E, Cleary P, Clark J, Weeks J. Quality of informed consent in cancer clinical trials: a cross-sectional survey. The Lancet 2001, 358: 1772-1777. PMID: 11734235, DOI: 10.1016/s0140-6736(01)06805-2.Peer-Reviewed Original ResearchConceptsClinical trialsCancer clinical trialsFuture patientsConsent formCross-sectional surveyNon-standard treatmentAdult patientsInformed consent processTrial participantsIncremental riskProviders' beliefsMultivariate analysisPatientsUncertainty of benefitPatient consentClinical researchStandard questionnaireInformed consentTrialsConsent processTherapeutic misconceptionCancer therapyConsentParticipantsTreatment
1991
Behavior changes after notification of HIV infection.
Cleary P, Van Devanter N, Rogers T, Singer E, Shipton-Levy R, Steilen M, Stuart A, Avorn J, Pindyck J. Behavior changes after notification of HIV infection. American Journal Of Public Health 1991, 81: 1586-90. PMID: 1746654, PMCID: PMC1405297, DOI: 10.2105/ajph.81.12.1586.Peer-Reviewed Original ResearchConceptsHIV infectionBlood donorsHIV-positive blood donorsNew York Blood CenterSexual behaviorShort-term behaviour changeUnsafe sexual behaviorHigh-risk behaviorsUnsafe sexual activityBehavior changeMedical historyScreening programDrug useMedical examinationBlood centersInfectionSexual activityWeeksParticipantsQuestionnaireHIVDonorsNursesVisitsPsychological characteristics
1988
Sociodemographic and behavioral characteristics of HIV antibody-positive blood donors.
Cleary P, Singer E, Rogers T, Avorn J, Van Devanter N, Soumerai S, Perry S, Pindyck J. Sociodemographic and behavioral characteristics of HIV antibody-positive blood donors. American Journal Of Public Health 1988, 78: 953-7. PMID: 3389433, PMCID: PMC1349859, DOI: 10.2105/ajph.78.8.953.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusRisk factorsBlood donorsMajor risk factorRisk of infectionWestern blot testSeropositive donorsImmunodeficiency syndromeImmunodeficiency virusStudy populationEtiologic agentBlot testStudy participantsLack of awarenessBehavioral characteristicsSupport programsDonorsSubjectsParticipantsHigh levelsSyndromeInfectionAntibodiesWomen